[ad_1]
According to the leading dementia research organization in the UK, the use of injections to combat the development and treatment of Alzheimer's disease could be offered to patients at this point 10 years.
The Alzheimer's Association, a British institution charged with research on disease treatment, dementia and nonprofit research, says a series of recent mutations of drugs and drugs that disrupt the work of the Harmful genes has led scientists to a "turning point" in the fight against the disease.
For decades, researchers have struggled to find a cure for Alzheimer's disease, which affects 46 million people worldwide, depending on the target of harmful proteins that accumulate in the body. brain.
However, the "striking" results of a recent experiment aimed at putting an end to the work of protein-regulating genes in children born with a rare spine problem, convinced scientists that they could adopt the same approach for people at higher risk of dementia.
In an interview with the British newspaper, James Beckett, head of research at the Society, said that our right to the spine would prevent the spread and development of specific forms of diseases, which could be available in less than 10 years.
The treatment, which uses "molecular scissors", will not change a person's basic genetic code, but rather how specific genes known to play a role in dementia communicate.
Such a drug would mainly benefit about 18,000 Britons among those most at risk of developing Alzheimer's disease, accounting for nearly 2% of the total number of Britons suffering from degenerative diseases, which mainly affect brain neurons.
These include people with the first stage of Alzheimer's disease, who can touch individuals in their early thirties. There is currently no treatment for any form of the disease.
"2019 will mark a turning point in the treatment of Alzheimer's disease, thanks to the genes that cause dementia," Beckett said.
"We have as much genetic knowledge as scientists 30 years ago, and we are now investing in understanding and exploiting it," he said.
Scientists now know 25 species of genes that significantly increase the risk of developing Alzheimer's disease, compared to a single discovery in 2012.
Researchers increasingly believe that the expression of these genes can be manipulated by CRISPR, a genetic modification technique that exploits a process used by the immune system to cut DNA from invasive bacteria, known as predatory bacteria.
The technology was widely popularized last November after Chinese scientist He Jian Kui claimed to use it to help produce the world's first genetically modified children.
Such a development would be illegal in the United Kingdom and condemned by the scientific community.
In contrast, the proposed treatment for Alzheimer's disease will take the form of a "messenger therapy", targeting how genes regulate the activity of harmful proteins, such as proteins (tau ) and (apo), in the brain.
Children with spinal muscular dystrophy, who have received this type of treatment, are still able to walk and do not rely on artificial respiratory protection, years after being expected.
Source link
